Bionomics Ltd (BNO.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2020 | 06-2019 | 06-2018 | 06-2017 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Operating Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 176 | -69 | -358 | -190 | -147 |
| Net Acquisitions | -693 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | 51 |
| Other Investing Activity | 382 | 208 | 418 | 923 | 972 |
| Investing Cash Flow | $-134 | $138 | $60 | $733 | $825 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 1,747 | 77 | 4,322 |
| Debt Repayment | -5,126 | -3,731 | -114 | -1,786 | -603 |
| Common Stock Issued | 2,240 | 7,073 | 302 | 110 | 21,076 |
| Other Financing Activity | -795 | -294 | 0 | 0 | 0 |
| Financing Cash Flow | $-3,681 | $3,048 | $1,935 | $-1,599 | $24,795 |
| Exchange Rate Effect | 33 | 61 | -151 | -8 | -7 |
| Beginning Cash Position | 9,610 | 17,460 | 31,495 | 34,926 | 19,799 |
| End Cash Position | 3,145 | 9,795 | 18,314 | 32,946 | 33,941 |
| Net Cash Flow | $-6,497 | $-7,726 | $-13,030 | $-1,973 | $14,149 |
| Free Cash Flow | |||||
| Capital Expenditure | -5 | -69 | -358 | -190 | -147 |
| Free Cash Flow | -5 | -69 | -358 | -190 | -147 |